Summary Hexokinase II (HKII) plays an important role in facilitating glucose uptake by skeletal muscle, heart, and adipose tissue in response to insulin. We have cloned and sequenced the proximal promoter region of the human HKII gene, determined the transcription start sites and screened the 2.0 kb of the proximal 5 ′ flanking region for variants in non-insulin-dependent diabetic patients and control subjects. We found three variants in this region, one in the 5 ′ untranslated region (G→C at + 217) and two in the promoter region (T→G at ±1043 and G→A at ±1159). The allele frequencies of these variants did not differ between the diabetic and control subjects and these variants are not associated with insulin resistance. Various segments of the human HKII promoter were tested for driving expression of the luciferase reporter gene. The proximal 500 bp and 400 bp of the promoter were sufficient to drive maximal activity in adipocyte (3T3F442A) and myocyte (C2C12F3) cell lines, respectively. This region of the promoter is GC-rich and contains eight consensus binding sites for the transcription factor Sp-1, five for AP-2, two putative response elements for each of insulin and cyclic AMP. The proximal 175 bases of the promoter retained only 7±15 % of maximal activity. Sequence elements located between positions ±304 and ±215 accounted for approximately 80 % of the basal HKII promoter. In addition, the region between ±215 and ±184 contains a negative regulatory element for expression in 3T3F442A but not in C2C12F3 cells. [Diabetologia (1997) 40 : 1461±1469] Keywords Hexokinase II, promoter, NIDDM, insulin resistance, diabetes mellitus.
the HKII gene in L6 and BCF-1B cells which led to an increase in glucose phosphorylation [11] . Hyperinsulinaemia was observed to be associated with elevated HKII mRNA levels in rat skeletal muscle and adipose tissue [12] and in human skeletal muscle [13] . On the other hand, hyperglycaemia was not found to influence HKII expression in these tissues in the rat [12] .
In the KKA Y mouse, an animal model of non-insulin-dependent diabetes mellitus (NIDDM), HKII mRNA and protein levels are significantly reduced in adipose tissue and skeletal muscle [14] . Furthermore, reductions in basal levels of glucose 6-phosphate [15] , in insulin-stimulated glucose uptake (reviewed in reference [16] ), and in the levels of HKII mRNA and enzyme production were observed [17] in skeletal muscle of NIDDM patients, suggesting a defect in glucose phosphorylation.
The human HKII gene has been screened for mutations in the coding region, and a total of 7 amino acid substitutions were found [18±21] . Although some of these substitutions may be associated with risk for NIDDM or insulin resistance, they are too infrequent to account for potentially more than 1±2 % of NIDDM cases. The regulatory sequences of the human HKII gene have not been screened. Genetic variability in response of the HKII gene to insulin may underlie insulin resistance in skeletal muscle and adipose tissue. Therefore, we screened the proximal promoter of the human HKII gene for variants that may potentially play an important role in its expression in these tissues and in response to various regulatory agents.
The activity of the proximal rat tumour-type HKII promoter has been studied by transient transfection experiments in rat hepatocytes and hepatoma cells [22, 23] . The HKII gene is not normally expressed in the liver, however, it is expressed at high levels in a variety of rapidly growing tumour cells, including hepatoma cells, which have a high glucose catabolic rate [24] . In attempts to define the molecular basis of this marked elevation in transcription of this gene in hepatoma cells, Ichihara et al. [22] performed transient transfection of hepatoma cells with plasmids containing various lengths (0.1, 0.6, and 1.3 kb) of the rat HKII promoter. They found that the plasmids containing the 1.3 and 0.6 kb had similar activities, whereas the 0.1 kb construct was almost completely inactive, indicating the presence of important cis-regulatory elements within the proximal 600 bp of the transcription start site. In a second study, Mathupala et al. [23] transfected hepatoma cells with a plasmid containing 4.3 kb of the rat proximal HKII promoter (tumour-type) and showed that promoter activity was enhanced upon treatment with glucose, insulin, glucagon, phorbol 12-myristate 13-acetate (PMA) and cyclic AMP. Incubation in the presence of insulin and glucose together resulted in maximal activation. However, these compounds had no effect on transcription of the endogenous HKII gene in primary hepatocytes and did not activate the 4.3 kb proximal promoter upon transient transfection of primary hepatocytes.
We have initiated characterization of the activity of the human HKII promoter in cell types that express the endogenous gene, namely skeletal muscle and adipose tissue. We have cloned and sequenced the human proximal promoter, determined the transcription start sites of the gene, screened for variants in NIDDM patients and control subjects, and performed analysis of promoter activity in skeletal muscle and adipocyte cell lines. We have identified certain regions of the proximal promoter that play major roles in its activity in these two types of cells.
Subjects, materials and methods
Isolation, sequencing and characterization of genomic clones that span the human HKII promoter. Isolation of human HKII genomic clones that contain exon 1 has been described [8] . Six of these genomic clones which hybridized to a 112 bp cDNA probe (±52 to + 60 with respect to the translation start site) were tested for the presence of promoter sequences. Exon 1 contains a unique Sst I site (Fig. 1) , therefore, these clones were digested with Sst I and subjected to Southern blot analysis using the same probe. Two of these clones (HKII-L19 and L-29) were chosen because they yielded the longest Sst I fragments (Fig. 1) . The hybridizing Sst I fragments (0.9 kb from clone HKII-L29 and 2.2 kb from clone HKII-L19) were subcloned into the vector pGEM-3Zf( + ) (Promega, Madison, Wis., USA) and sequenced (Sequenase kit; US Biochemicals, Cleveland, Ohio, USA). The 0.9 kb Sst I subclone extended In order to determine whether genomic clone HKII-L19 had additional sequences 5 ′ upstream of the distal Sst I site ( Fig. 1) , this clone was used as template for PCR amplification using vector primer T7 and HKII primer 1.23 (Table 1 , Fig. 1 ) using the Expand Long Template PCR System (Boehringer Mannheim, Indianapolis, Ind., USA) according to the manufacturer's protocol. An amplification product of approximately 2.7 kb was obtained.
Determination of the transcription initiation site. The transcription initiation site of the human HKII gene was determined by primer extension analysis [25] . Total cellular RNA from human skeletal muscle and adipose tissue samples was isolated using the guanidinium isothiocyanate-phenol-chloroform method [26] . The antisense oligonucleotide primer 5′GCGGATTTTCTTAGCTGGGTG-3′, position ±376 to ±396 with respect to the translation start site (underlined in Fig. 2 ) was used in primer extension analysis as previously Proximal 540 bp of the rat HKII promoter aligned with human promoter sequence (conserved nucleotides marked with vertical lines). The transcription initiation site marked with + 1. Putative TATA-like box and CAAT box are in bold; the two Alu repeats in lower case. Putative transcription factor binding sites (underlined) were identified by comparison with sequences in the ªTranscription Element Search Databaseº (http:// agave.humgen.upenn.edu/cgi-bin/tess). The oligonucleotide primer used for primer extension analysis is double underlined described [5] . The procedure was modified as follows: 25 mg of RNA was annealed at 62°C for 16 h, extension was done at 42°C for 1 h using 400 U of SuperScriptII reverse transcriptase (BRL, Grand Island, N. Y., USA) and the reaction products were electrophoresed on an 8 % polyacrylamide-7 Murea-sequencing gel. A sequencing ladder was generated using the 0.9 kb Sst I fragment derived from genomic clone L29 as template and the same labelled oligonucleotide as primer.
Screening for variants and association of variants with insulin sensitivity. The screening for variants in the promoter region and in the 5 ′ untranslated region of the HKII gene was performed by single strand conformation polymorphism (SSCP) analysis and sequencing of variants as previously described [20] . The primers and restriction enzymes used in SSCP analysis are shown in Table 1 .
The association of variants with insulin sensitivity was determined in 112 patients with NIDDM (56 men, 56 women, age 63 ± 1 years, body mass index 30 ± 1 kg/m 2 , duration of diabetes 8 ± 1 years, 49 % treated with diet, 29 % with oral drugs and 22 % with insulin) and in 97 control subjects with normal glucose tolerance (84 men, 13 women, age 55 ± 1 years, body mass index 27 ± 0 kg/m 2 ). Insulin sensitivity was determined by the euglycaemic hyperinsulinaemic clamp technique (insulin infusion of 80 mU ⋅ m ) in patients with NIDDM) as previously described in detail [27] .
Preparation of nested deletions of the HKII promoter. Starting with the 0.9 and 2.2 kb Sst I-subclones of genomic clones L29 and L19, respectively, nested deletions of the HKII promoter were generated either by cutting with the restriction enzymes shown in Figure 1 (with the 3 ′ end of all segments generated by cleavage with Eco0109I) or by PCR amplification of the desired segment. The sequence of oligonucleotide primers used for PCR amplification is given in Table 1 . Digested samples were blunt-ended and purified by electrophoresis on a 1 % low-melting-point agarose gel followed by Qiaex gel extraction purification (Qiagen Inc., Chatsworth, Calif., USA) and cloned into the SmaI site of the luciferase reporter vector PXP1 (ATCC #37576, [28, 29] ).
The ±4.0 kb HKII construct was prepared in two steps. First, the 2.3 kb Sal I/(blunt-ended)/SstI-fragment from genomic clone L19 was cloned into the BamHI (blunt-ended)-Sst I site of PXP1 vector. This subclone was designated luc ±4.0/±1.7. Next, a 1.8 kb Sst I/Eco0109I fragment (Fig. 1, ±1692 to + 106) was isolated, the EcoO109I-end blunted and cloned into the Sal I(blunt-ended)-Sst I site of subclone luc ±4.0/±1.7 resulting in the ±4.0 kb HKII construct.
The sequence of all nested deletions was determined using vector primers LUC-MC5 ′ and LUC-MC3 ′ (Table 1 ) and several HKII promoter primers. The 3 ′ ends of the nested deletion clones extended to nucleotide + 106. Plasmid DNA for transfection experiments was prepared using the Qiagen plasmid kit (Qiagen Inc) according to the manufacturer's protocol.
Internal deletions of various lengths of the GC-rich region located between positions ±215 and ±180 were frequently observed when we attempted to amplify, using genomic clones as templates, segments encompassing this region. One of these deletions (between ±215 and ±184) was also used in transfection assays.
Cell culture and transient transfection. The mouse myoblast cell line C2C12F3 [30] , kindly provided by Dr. H. Weintraub's laboratory (Fred Hutchinson Cancer Research Center, Seattle, Wash., USA), was maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 2 mmol/l l-glutamine and 20 % fetal bovine serum in a 5 % CO 2 /air environment at 37°C. Cells were induced to differentiate into myotubes in DMEM medium supplemented with 2 % horse serum. Approximately 90 % of cells were differentiated into multinucleate myotubes after 3 days of culture in differentiation medium.
The mouse preadipocyte cell line 3T3F442A [31] , kindly provided by Dr. M. Reina (University of Barcelona, Spain), was grown in DMEM supplemented with 2 mmol/l l-glutamine, 8 mg/l biotin, 15 mmol/l Hepes and 10 % fetal bovine serum. Cells were differentiated into adipocytes in growth medium further supplemented with 2 nmol/l T 3 and 17 nmol/l bovine insulin. Differentiation was followed by staining lipid droplets with Red Oil O.
Both cell lines were transfected in 24-well plates using the lipofectin reagent (BRL, Grand Island, N. Y., USA) basically following the manufacturer's protocol. Before harvesting, C2C12F3 and 3T3F442A cells were kept in differentiation medium for 1 and 4 days respectively.
For insulin induction studies, C2C12F3 and 3T3F442A cells were transfected and then maintained in differentiation medium for 3 to 5 days, after which they were incubated for 8 to 48 h in serum-, insulin-and glucose-free or glucose-containing growth medium. Subsequently, 10±100 nmol/l insulin, 25 mmol/l glucose or both together were added into the medium and the cells incubated for an additional 4 to 48 h. Cells were harvested, washed once with phosphate buffered saline and lysed with 100 ml of lysis reagent (Promega, Madison, Wis., USA). We used 10 ml of the cell lysate to determine protein concentration [32] . Luciferase and b-galactosidase activities were determined using 20 ml of the cell extract as previously described [33] . Each experiment included two independent control transfections. A promoterless vector, PXP1, was used to correct for background activity and a luciferase reporter gene driven by Rous sarcoma virus promoter, pRSVL 5 ′ [28], was used as an external standard to which HKII promoter activities were compared. The plasmid pnCMVlacF, a lacZ reporter gene driven by the cytomegalovirus promoter/enhancer, was used to correct for differences in transfection efficiency.
Results and discussion
Sequence and functional properties of the human HKII gene promoter. We have isolated the proximal promoter of the human HKII gene and sequenced 2.0 kb immediately upstream of the transcription initiation site (Fig. 2) . Alignment of the human and rat promoter sequences revealed high conservation up to 450 bp upstream of the transcription initiation site (Fig. 2) . The promoter sequence was analysed for transcription factor binding sites using the ªTranscrip-tion Element Searchº database (http://agave.humgen.upenn.edu/cgi-bin/tess). The human HKII promoter has a TATA-like box (AATAA) at position ±13, a CCAAT-box at ±66, and an inverted CCAATbox (also referred to as a Y-box) at position ±118 (Fig. 2) . The proximal 550 bp region of the promoter is GC-rich and contains eight putative consensus binding sites for the Sp-1 family of transcription factors [34, 35] . The human HKII promoter also contains five putative binding sites for AP-2 [36, 37] , four for GCF [38] , two for CTF-NF-Y ([39±42] for review see [43] ) and one for ODC-NF-1 [44] . In addition, there are two putative cyclic AMP (CRE) and two insulin response elements (IRE) within this proximal region.
The ubiquitously expressed heteromeric transcription factor NF-Y binds to the CCAAT and Y-boxes and activates transcription of a variety of genes [39± 42]. GCF and ODC-NF1 were shown to interact with GC-rich regions and repress transcription from promoters of the epidermal growth factor receptor, b-actin, calcium-dependent protease and ornithine decarboxylase genes [38, 44] . A protein kinase A-dependent signal transduction pathway was proposed to mediate regulation of transcription of the PEPCK and tyrosine aminotransferase gene promoters by insulin via a cAMP response element (CRE) [45±47].
Osawa et al. [48] , recently observed that cAMP induces activity of a reporter gene driven by rat HKII promoter constructs. Furthermore, they showed that the CCAAT box and an adjacent CRE cumulatively mediate the inductive effect of cAMP. Both of these elements, including the spacing in-between, are completely conserved in the human HKII promoter (at ±44 for CRE and ±62 for CCAAT in Fig. 2 ). The potential role of these putative transcription factors on the regulation of human HKII gene remains to be established.
The human (but not the rat) HKII promoter was found to contain one complete and one truncated Alu repeat elements (lower case letters in Fig. 2 ) which belong to the relatively old J-subfamily of Alus [49, 50] . The upstream Alu is truncated at its 3 ′ end by approximately 195 bp and is flanked by 14 bp direct repeats and is oriented in the opposite direction of the complete downstream Alu element.
The transcription initiation sites of the human HKII gene. Primer extension analysis was used to determine the transcription start site(s) of the human HKII gene. An end-labelled HKII antisense oligonucleotide primer, from ±376 to ±396 with respect to the translation start site (underlined in Fig. 2) , was hybridized to total RNA prepared from human skeletal muscle or adipose tissue and extended by reverse transcription. The length of the resulting fragments indicated a major transcription initiation site of 449 bp upstream of the translation initiation codon (Fig. 3) . In skeletal muscle there were minor sites at ±12, ±20, ±39, ±40 and ±41, which were not observed in adipose tissue. These results differ from those reported for the rat HKII [5] in which the transcription initiation site in rat adipose tissue was mapped to position + 19 with respect to the major start site in human tissues (Fig. 2) . Additional start sites were found at positions + 18, + 16, + 15, ±4 and ±5 (with respect to the start site in human HKII) in the rat AH130 hepatoma cell line [22] . The potential role of these different initiation sites remains to be established.
Sequence variants of the promoter region. SSCP analysis revealed the previously reported variant G→C at position + 217 [21] in the 5 ′ untranslated region and two new variants in the promoter region of the HKII gene (T→G at position ±1043 and G→A at position ±1159) (Fig. 1) . The frequency of the C allele at position + 217 was 0.183 in patients with NIDDM and 0.268 in control subjects (p = NS between the groups). The allele frequency of the T→G substitution at position ±1043 (Fig. 1 ) was 0.03 in patients with NIDDM and 0.06 in control subjects and the allele frequency of the substitution G→A at position ±1159 (Fig. 1 ) was 0.473 in patients and 0.464 in control subjects (p = NS between groups). None of these variants was associated with high fasting, 1-h or 2-h insulin levels (data not shown). The association of the + 217 and ±1159 variants with insulin resistance was evaluated by the euglycaemic clamp. Neither of these variants was associated with low rates of whole body glucose uptake in NIDDM or control subjects (Table 2 ). In addition, the ±1043 variant (T→A) was not associated with reduced rates of whole body glucose uptake (data not shown). Thus, it seems unlikely that any of these variants contributes to insulin resistance.
Functional analysis of the HKII promoter. A series of nested 5 ′ deletions of the HKII promoter driving Fig. 3 . Primer extension analysis with human adipose tissue and skeletal muscle RNA. A 32 P-labelled oligonucleotide primer (Fig. 2) was hybridized with 25 mg of total RNA extracted from human adipose tissue (lane 1) and skeletal muscle (lane 2). The extended products were run on an 8 % sequencing gel adjacent to the DNA sequencing ladder generated by the same labelled oligonucleotide with a subclone of the human hexokinase gene as template. The major band is marked with a thick arrow and minor sites with thin arrows expression of the luciferase reporter gene were tested for activity by transient transfection of the murine C2C12F3 skeletal muscle and 3T3F442A adipocyte cell lines. Both cell lines have been shown to express endogenous HKII upon differentiation [5] . Relative HKII promoter activities of the nested deletions, shown in Figure 4 , were found to be similar in both cell lines. In C2C12F3 cells, deleting the promoter region from ±4000 bp to ±304 bp resulted in no statistically significant decrease in activity. Therefore, the activity of the ±1692 construct was set as 100 % (Fig. 4) . Deletion from ±304 bp to ±254 bp resulted in loss of approximately 60 % of activity, deletion to ±174 bp further loss of 25 % of activity, and deletion to ±97 bp resulted in additional loss of 5 % of activity. This indicates that the CCAAT and Y-boxes together with the two Sp-1 elements located within this 174 bp region are not sufficient to support maximal basal promoter activity. The activity of the HKII promoter in 3T3F442A cells differed from that in C2C12F3 in that deletion of the region between ±505 bp and ±406 bp resulted in approximately 35 % decrease in activity. It appears that the core promoter elements responsible for basal promoter activity in skeletal muscle and adipose cells are located within the proximal 400 bp and 500 bp, respectively.
The sequence variants at positions ±1159 and ±1043 of the human HKII promoter, which we observed to be equally represented among NIDDM and normal subjects, are unlikely to have any functional impact since deletion of the region between ±1692 and ±964 did not alter activity of the proximal promoter.
An internal deletion extending from ±184 to ±215 was prepared from the ±254 promoter construct. This deletion encompassed a highly GC-rich region that contains three consensus binding sites for Sp1, 2 for each of AP-2 and GCF and one for ODC-NF-1. Surprisingly, the activity of the promoter construct with this internal deletion was on average 1.46 ± 0.53 fold that of the full ±254 construct (three independent transfections done in triplicate; p = 0.007) when transfected into 3T3F442A adipocyte cells. However, this internal deletion had no effect on promoter activity in the C2C12F3 cell line. This indicates that the deleted segment may contain sites of interaction with negative regulatory factors, such as ODC-NF-1, which is known to repress Sp1 activation of the ornithine decarboxylase promoter in a tissue-specific manner [44] . These results also indicate that the region between ±254 and ±215 contains important positive promoter elements since a major loss in activity was observed in deleting the promoter from ±254 to ±174. Alternatively, the increase in activity associated with the internal deletion may have been the result of relocation of the ±254 to ±215 region closer to the transcription initiation site.
In conclusion, functional analysis of the human HKII promoter deletions indicates that two sets of positive regulatory sequence elements located between 304 bp and 215 bp from the major transcription start site account for approximately 80 % of the basal HKII promoter activity. One set is located in the 5 ′ half and the other in the 3 ′ half of this approximately 100 bp segment, the sequence of which is highly conserved (88 % identity) between human and rat. A putative CRE is located in this region. In addition, the highly GC-rich region between nucleotides ±215 and ±184 contains a negative regulatory element, at least in 3T3 cells. Rates of whole body glucose uptake (mmol ⋅ kg
, as evaluated by the euglycaemic clamp technique, of control and NIDDM patients with different genotypes at the G → C (position + 217) and the G → A (at position −1159) polymorphism in the 5′ untranslated and promoter regions, respectively. Number of subjects in parenthesis Fig. 4 . Functional analysis of the human HKII promoter. C2C12F3 myoblasts and 3T3F442A preadipocytes were transiently transfected with different HKII 5 ′ deletion-luciferase fusion constructs. C2C12F3 cells were harvested 40 h after transfection and 3T3F442A cells were harvested 4 days after differentiation into adipocytes. Cell lysates were assayed for luciferase and b-galactosidase activities. Luciferase activity was first corrected for background activity of the PXP1-vector and then normalized with b-galactosidase activity to correct for differency in transfection efficiency. The data represent mean ± SEM of six independent experiments. Duplicate transfections were performed in each experiment with two to three different plasmid preparations. The activity of the ±1692 HKII construct was set at 100 %. * p < 0.01, ** p < 0.001 (Student's t-test) indicate statistically significant losses in activity resulting from the deletion of any one segment of the promoter Recently, activities of nested deletions of promoter constructs of the rat HKII were analysed by transfection of rat L6 myotubes [48] . In contrast to the human HKII promoter, maximal basal activity of the proximal rat promoter in L6 myotubes was achieved by constructs containing only 157 bp. A similar length of the human promoter had only 15 % activity in C2C12F3 cells.
Activity of the proximal HKII promoter in response to insulin and glucose. We investigated whether insulin or glucose would induce activity of the HKII promoter by transient transfection of C2C12F3 and 3T3F442A cells with luciferase vectors containing 964, 406, 304, 174 and 97 bp (and one containing 4.0 kb in case of 3T3F442A) of the proximal HKII promoter as described under Materials and methods. Small (less than 1.5-fold) and variable inductive effects of insulin and glucose were observed which could not be used to localize insulin response elements. The steady-state level of HKII mRNA increased by only two-fold upon treatment of 3T3F442A cells with insulin using the same protocol used in transfection experiments (data not shown).
This result was unexpected since insulin was previously shown to increase the steady-state levels of HKII mRNA by six-and three-fold in fully differentiated 3T3F442A and C2C12 cells, respectively [5] . However, it was not determined whether insulin had any effect on the transcription rate of the HKII gene in these cell lines. In vivo, hyperinsulinaemia was observed to be associated with elevated HKII mRNA levels in rat skeletal muscle and adipose tissue [12] , and in human skeletal muscle [13] . On the other hand, hyperglycaemia was not found to influence HKII expression in these tissues in the rat [12] .
Our results suggest that either the insulin and glucose response elements are located outside of the 4.0 kb region of the proximal promoter, or that the cell lines we transfected were not sufficiently differentiated to give a significant response.
Various cis-acting sequences that mediate insulindependent regulation of transcription have been reported in promoters of genes encoding phosphoenolpyruvate carboxykinase (PEPCK) [45] , c-fos [51, 52] , amylase [53] , glyceraldehyde 3-phosphate dehydrogenase (GAPDH) [54, 55] , glugacon [56, 57] , malic enzyme [58] , delta 1-crystallin [59] , prolactin [60] , b-actin [61] , insulin-like growth factor I-binding protein [62] , tyrosine aminotransferase [46] , thyrotropin receptor [63] and fatty acid synthase [64] . There seems to be no unique sequence found so far to mediate the effects of insulin. Two putative sequences found in the promoter of HKII gene resemble insulin responsive sequences found in other genes [51±64]. However, neither of these sites is totally conserved between human and rat.
Osawa et al. [65] recently observed that insulin induced by 3.5-fold the activity of a reporter gene driven by 487 bp of the proximal rat HKII promoter transfected into rat L6 myotubes but did not define the insulin response elements within this construct. Interestingly, these authors also showed that the induction of HKII by insulin was blocked by treatment with either wortmannin or rapamycin, suggesting that a phosphatidylinositol 3-kinase (PI 3-kinase)/ p70/p85 ribosomal S6 protein kinase (p70 s6 k )-dependent pathway may transduce the action of insulin on HKII gene expression. In addition, both insulin and glucose were shown to activate the rat HKII promoter (4.3 kb) in transient transfection of AS-30D hepatoma cells [23] .
More reliable analysis of the level at which the HKII gene is regulated by glucose and insulin in various tissues and of the cis-DNA elements that mediate response to these agents in vivo would best be accomplished using transgenic mice that harbour various lengths of the HKII promoter driving expression of a reporter gene. 
